Chase AIPricingFAQs
Display currency
Loading news…

KAI Pharmaceuticals

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
South San Francisco, California, United States Founded 2002 10001+ employees For Profit

KAI Pharmaceuticals discovers and develops novel therapeutics for cardiovascular diseases, kidney diseases and pain.

KAI Pharmaceuticals was acquired by Amgen in 2012 for $315M.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
1
Patents
26

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2
Active products
5
Patents granted
26
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene

Company Info

Founded
2002
Employees
10001+
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
14
HQ
South San Francisco, California, United States
Region
San Francisco Bay Area, West Coast, Western US
Diversity spotlight
Women Founded
Exit date
Apr 10, 2012

Signals & Scores

Heat score
High
Trend (7d)
0.9
Trend (30d)
2.2
Trend (90d)
1.5
1
professional contacts at KAI Pharmaceuticals
Contact execs at KAI Pharmaceuticals

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to KAI Pharmaceuticals

Loading news…

FAQs about KAI Pharmaceuticals

People who checked this page also checked these

Browse the full Acquirezy directory.
KAI Pharmaceuticals - Company Profile, Full Acquisitions List, Funding and Investments